CRSP
CRISPR Therapeutics AG
NASDAQ · Healthcare · Biotechnology · CH
$50.04
+1.60%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 59.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.77x
- Price / sales
- 361.30x
- Price / cash flow
- -13.09x
Enterprise value
- Enterprise value
- $3.3B
- EV / sales
- 243.27x
- EV / EBITDA
- -7.18x
- EV / EBIT
- -6.13x
- Market cap
- $4.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026